New fair price for Gilead's remdesivir? Below $2,800 if dexamethasone lives up to its COVID-19 promise How much will healthcare costs go up next year? It's anyone's guess, says PwC U.K. launches new national COVID-19 test validation project Here's a look at doctors' pre-COVID-19 net worth, including how much their houses cost Fauci says government faces financial risk in race to find COVID-19 vaccine Biopharma roundup: Dexamethasone could thwart remdesivir pricing plans; Greek researchers tap ancient med to treat novel virus Healthcare roundup: HHS defends ending funding to 13 test sites Featured Story | Wednesday, June 24, 2020 Nearly two months ago, an influential drug cost watchdog pegged $4,460 as the fair price for Gilead Sciences’ authorized COVID-19 therapy remdesivir. But on coronavirus time, that's an eternity—and a lot has changed since then. read more |
| |
|---|
|
Top Stories Wednesday, June 24, 2020 Healthcare costs for employer-sponsored plans are likely to increase in 2021, but it remains unclear by how much due to massive changes prompted by the COVID-19 pandemic, a new report finds. read more Wednesday, June 24, 2020 The U.K. government is launching a national research program, in collaboration with a number of universities, NHS trusts and medical research groups, to evaluate new coronavirus diagnostic tests and how well they perform in different settings. read more Wednesday, June 24, 2020 Doctors have taken a financial hit in the era of COVID-19. Here's a look at what many of them said before the pandemic about their financial picture, including how many have student loans, how large their homes and mortgages are and their estimated net worth. read more Tuesday, June 23, 2020 Infectious disease expert Anthony Fauci told lawmakers that the federal government is only taking on financial risk in the race to develop a COVID-19 vaccine, and won't compromise on safety and effectiveness. read more Wednesday, June 24, 2020 Dexamethasone's swift rise as a COVID-19 treatment could hurt remdesivir's final price tag, according to an updated ICER assessment published Wednesday. The U.K. is tapping universities, NHS trusts and researchers in a new COVID test validation effort. Plus, a Greek study showed an ancient drug could curb severe COVID-19. read more Wednesday, June 24, 2020 Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more |
